INC-106

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameINC-106

Drug Alias Nameangiotensin II mAb (Inncardio/Queen Mary and Westfield College)angiotensin II type I receptor monoclonal antibody (Inncardio/Queen Mary Univeristy)INC-106

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists

TargetsAngiotensin II Receptor Type 1

Therapy Area/IndicationsCoronary Restenosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesQueen Mary University Of London

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLong-E International

Active IndicationsN/A

Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A